Social network methods for HIV case-finding among people who inject drugs in Tajikistan

被引:17
作者
Kan, Maxim [1 ]
Garfinkel, Danielle B. [2 ]
Samoylova, Olga [1 ]
Gray, Robert P. [3 ]
Little, Kristen M. [4 ]
机构
[1] PSI Cent Asia, Alma Ata, Kazakhstan
[2] PSI, Program Analyt, Washington, DC USA
[3] PSI, Washington, DC USA
[4] PSI, HIV TB Dept, Washington, DC USA
关键词
HIV; AIDS; Central Asia; Tajikistan; case-finding; network; respondent driven sampling; HIDDEN POPULATIONS; RISK; INFECTION; SERVICES;
D O I
10.1002/jia2.25139
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: HIV testing programmes have struggled to reach the most marginalized populations at risk for HIV. Social network methods such as respondent-driven sampling (RDS) and peer-based active case-finding (ACF) may be effective in overcoming barriers to reaching these populations. We compared the client characteristics, proportion testing HIV positive (yield), and number of new cases found through two RDS strategies and an ACF approach to HIV case-finding among people who inject drugs (PWID) in Tajikistan. Methods: Routine programme data from adult PWID recruited to testing under the HIV Flagship Project in Tajikistan were analysed to compare client demographic and clinical characteristics across the three approaches. We also compared the number of previously untested clients, the number of new HIV cases found, and the yield across the case-finding strategies, and evaluated predictors of new HIV diagnosis using fixed-effects logistic regression. Results: From 24 October 2016 to 30 June 2017, Flagship tested 10,300 PWID for HIV, including 2143 under RDS with unrestricted waves (RDS1, yield: 1.5%), 3517 under restricted RDS (RDS2, yield: 2.6%), and 4640 under ACF (yield: 1.5%). Clients recruited under ACF were similar in age (35.8 vs. 36.8) and gender (91% vs. 90% male) to those recruited through RDS, though ACF clients were more likely to report being a first-time tester (85.1% vs. 68.3%, p<0.001). After controlling for age, sex, previous testing history and accounting for clustering at the site level, we found that clients tested under both RDS1 (aOR: 1.74, 95% CI: 1.04 to 2.90) and RDS2 (aOR: 1.54, 95% CI: 1.11 to 2.15) had higher odds of testing newly positive for HIV relative to clients recruited through ACF. We did not find significant differences in the odds of new HIV infection between those recruited from RDS1 versus RDS2 (aOR: 1.12, 95% CI: 0.67 to 1.86). Conclusions: RDS-based interventions resulted in higher yields and overall case-finding, especially when recruitment was restricted. However, ACF identified a higher proportion of first-time testers. To find at least 90% of PWID living with HIV in Tajikistan, it may be necessary to implement multiple case-finding approaches concurrently to maximize testing coverage.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Unmet needs and barriers to services among people who inject drugs with HIV in the United States
    Dasgupta, Sharoda
    Tie, Yunfeng
    Beer, Linda
    Broz, Dita
    Vu, Quan
    JOURNAL OF HIV-AIDS & SOCIAL SERVICES, 2021, 20 (04) : 271 - 284
  • [32] Acute HIV infection transmission among people who inject drugs in a mature epidemic setting
    Escudero, Daniel J.
    Lurie, Mark N.
    Mayer, Kenneth H.
    Weinreb, Caleb
    King, Maximilian
    Galea, Sandro
    Friedman, Samuel R.
    Marshall, Brandon D. L.
    AIDS, 2016, 30 (16) : 2537 - 2544
  • [33] Modelling a disease-relevant contact network of people who inject drugs
    Rolls, David A.
    Wang, Peng
    Jenkinson, Rebecca
    Pattison, Phillipa E.
    Robins, Garry L.
    Sacks-Davis, Rachel
    Daraganova, Galina
    Hellard, Margaret
    McBryde, Emma
    SOCIAL NETWORKS, 2013, 35 (04) : 699 - 710
  • [34] Opening up the HIV epidemic: a review of HIV seropositive status disclosure among people who inject drugs
    Nasarruddin, Aishah M.
    Saifi, Rumana A.
    Othman, Sajaratulnisah
    Kamarulzaman, Adeeba
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2017, 29 (05): : 533 - 540
  • [35] Examining non-AIDS mortality among people who inject drugs
    Mathers, Bradley M.
    Degenhardt, Louisa
    AIDS, 2014, 28 : S435 - S444
  • [36] ESTIMATING CAUSAL EFFECTS OF HIV PREVENTION INTERVENTIONS WITH INTERFERENCE IN NETWORK-BASED STUDIES AMONG PEOPLE WHO INJECT DRUGS
    Lee, Tingfang
    Buchanan, Ashley L.
    Katenka, Natallia, V
    Forastiere, Laura
    Halloran, M. Elizabeth
    Friedman, Samuel R.
    Nikolopoulos, Georgios
    ANNALS OF APPLIED STATISTICS, 2023, 17 (03) : 2165 - 2191
  • [37] Individual and network factors associated with HCV treatment uptake among people who inject drugs
    Falade-Nwulia, Oluwaseun
    Sacamano, Paul
    McCormick, Sean D.
    Yang, Cui
    Kirk, Greg
    Thomas, David
    Sulkowski, Mark
    Latkin, Carl
    Mehta, Shruti H.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 78
  • [38] Social support and HIV management among people who inject drugs: in-depth interviews in Delhi, India
    Kaptchuk, Rose P.
    Kant, Aastha
    Shekhawat, Surendra S.
    Baishya, Jiban
    Sinha, Archit
    Kedar, Ashwini
    Khanna, Saisha
    Mcfall, Allison M.
    Solomon, Sunil S.
    Mehta, Shruti H.
    Lucas, Gregory M.
    HARM REDUCTION JOURNAL, 2025, 22 (01)
  • [39] Rapid Identification and Investigation of an HIV Risk Network Among People Who Inject Drugs –Miami, FL, 2018
    Hansel Tookes
    Tyler S. Bartholomew
    Shana Geary
    James Matthias
    Karalee Poschman
    Carina Blackmore
    Celeste Philip
    Edward Suarez
    David W. Forrest
    Allan E. Rodriguez
    Michael A. Kolber
    Felicia Knaul
    Leah Colucci
    Emma Spencer
    AIDS and Behavior, 2020, 24 : 246 - 256
  • [40] A new outbreak of HIV infection among people who inject drugs during the COVID-19 pandemic in Greece
    Sypsa, Vana
    Roussos, Sotirios
    Tsirogianni, Efrossini
    Tsiara, Chrissa
    Paraskeva, Dimitra
    Chrysanthidis, Theofilos
    Chatzidimitriou, Dimitrios
    Papadimitriou, Evaggelia
    Paraskevis, Dimitrios
    Goulis, Ioannis
    Kalamitsis, George
    Hatzakis, Angelos
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 117